Recruiting
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
NCT07210632
- Conditions
- Brain Cancer, Brain Diseases, Brain Neoplasms, +18 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States